JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 1991; 18:613-620
© 1991 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyazaki, A
Right arrow Articles by Corday, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyazaki, A
Right arrow Articles by Corday, E

Retrograde coronary venous administration of recombinant tissue-type plasminogen activator: a unique and effective approach to coronary artery thrombolysis

A Miyazaki, H Tadokoro, JK Drury, L Ryden, RV Haendchen, and E Corday

Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.

Recent studies of interventional therapy by way of the coronary venous system have demonstrated that it can protect acutely ischemic myocardium. To evaluate the efficacy of coronary venous retroinfusion compared with systemic intravenous administration of recombinant tissue-type plasminogen activator (rt-PA), 14 dogs were studied with a copper coil-induced thrombus in the left anterior descending coronary artery. The rt-PA (24,000 fluorescence units/kg) was administered continuously, either intravenously (n = 8) or retrogradely (n = 6), for 30 min beginning 60 min after coronary occlusion. Thrombolysis was determined by repetitive coronary angiography. All dogs were killed 3 h after termination of rt-PA infusion and infarct size was measured by the triphenyltetrazolium chloride staining technique. Complete thrombolysis occurred in five of the six dogs in the retroinfusion group and four of the eight dogs in the systemic intravenous infusion group. Partial lysis was achieved in two dogs treated by intravenous infusion. Lysis did not occur in one dog treated with retroinfusion and in two dogs treated with intravenous infusion. Time to thrombolysis was 13.4 +/- 2.3 min in the retroinfusion group versus 27.8 +/- 4.8 min in the intravenous group (p less than 0.001). Myocardial functional recovery in the ischemic zone measured by two-dimensional echocardiography 60 min after reperfusion was significant only in the retroinfusion group (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 Circ Cardiovasc InterventHome page
T. Siminiak and J. Lipiecki
Trans-Coronary-Venous Interventions
Circ Cardiovasc Intervent, October 1, 2008; 1(2): 134 - 142.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. P. Singh, S. Houser, E. K. Heist, and J. N. Ruskin
The Coronary Venous Anatomy: A Segmental Approach to Aid Cardiac Resynchronization Therapy
J. Am. Coll. Cardiol., July 5, 2005; 46(1): 68 - 74.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
H. L. Lazar
Coronary sinus retroperfusion: Can forward progress still be achieved by using a backward technique?
J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1549 - 1552.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
F. J. Giordano
Retrograde coronary perfusion: a superior route to deliver therapeutics to the heart?
J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1129 - 1131.
[Full Text] [PDF]


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1991 by the American College of Cardiology Foundation.